The financials
Exelixis, Inc. by the numbers
Exelixis, Inc. (EXEL) reported revenue of $611M in Q1 2026 (quarter ended April 3, 2026), up 10.0% from the same quarter a year earlier. That came with a gross margin of 97% and net income of $210M (34% of revenue). For the full year FY2025, revenue was $2.32B (+7.0% year on year) and net income $783M. Its largest product in 2026-Q2 was Product Gross at $813M, 87% of the disclosed total, just ahead of License at 6.4%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $611M | $555M | +10.0% |
| Gross profit | $591M | $536M | +10% |
| Operating income | $251M | $187M | +35% |
| Net income | $210M | $160M | +32% |
| Diluted EPS | $0.79 | $0.55 | +44% |
| Product | Revenue | Share |
|---|---|---|
| Product Gross | $813M | 87% |
| License | $60M | 6.4% |
| Collaboration | $56M | 6.0% |
| Cometriq | $2.4M | 0.3% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $686.7M (+2.7%)
License grew +21% year on yearProduct Gross +9.1% year on year
Segment Latestquarter on quarteryear on year
- Product Gross$812.8M$812.8MQoQ +2.2%year on year +9.1%+2.2%+9.1%
- License$59.8M$59.8MQoQ +5.0%year on year +21%+5.0%+21%
- Collaboration$55.7M$55.7MQoQ -0.30%year on year +15%-0.30%+15%
- Cometriq$2.4M$2.4MQoQ +7.8%year on year +12%+7.8%+12%
- Service−$4.1M−$4.1MQoQ -year on year ---
- Product Sales Discounts And Allowances−$239.8M−$239.8MQoQ -year on year ---